Ophthalmology Doctors in Provo, UT Accepting Medicare

21 Ophthalmology doctors found. Showing 1 - 20

Jonathan B Gunther, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-379-2904    Fax: 801-379-2959

Thomas Dyreng Myers, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 280 River Park Dr, Suite 220, Provo, UT 84604 Phone: 801-224-3565    Fax: 801-224-3567

Dr. Matthew Reed Parsons, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-379-2959

Dr. James G Theurer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-379-2959

Norman Kent Linton, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-374-0163

Dr. Michael J Lloyd, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 204, Provo, UT 84604 Phone: 801-357-7373    Fax: 801-357-7217

Dr. Jack Dunyon Stringham Ii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 500, Provo, UT 84604 Phone: 801-357-7704

Christopher Ricks, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-374-0163

Jeffrey Paul Gardiner, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W, Suite 204, Provo, UT 84604 Phone: 801-357-7373    Fax: 801-357-7217

Dr. Justin Wilkinson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-374-0163

Bradley Henriksen, M.D. Ophthalmology - Pediatric Ophthalmology and Strabismus Specialist Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818

Dr. Joseph S Schmutz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818

Richard Paul Corey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 500, Provo, UT 84604 Phone: 801-357-7704    Fax: 801-357-7424

Dr. Stephen L Donaldson, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1055 N 500 W Ste 201, Provo, UT 84604 Phone: 801-375-6565    Fax: 801-373-9750

Dr. Larry Noble, MD MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W, Suite A, Provo, UT 84604 Phone: 801-357-7373    Fax: 801-357-7217

Ryan Franklin Isom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 500, Provo, UT 84604 Phone: 801-357-7704    Fax: 801-357-7424

Austin James Woolley, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818

Dr. Michael Reed Christensen, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1055 N 300 W Ste 204, Provo, UT 84604 Phone: 801-357-7373

Mason Antone Schmutz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-374-1818    Fax: 801-374-0163

Mark A. Richey, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1145 N 500 W, Ste A4, Provo, UT 84604 Phone: 801-354-8225    Fax: 801-418-0941

News Archive

Study suggests Golgi as potential drug target for Alzheimer's treatment

Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.

Lentigen awarded $1.23M grant under Patient Protection and Affordable Care Act

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that it will receive $1,235,306 in cash grants from the U.S. Government under the Patient Protection and Affordable Care Act.

Weight loss of top performers has positive effect on individuals' weight loss goals

The weight loss industry in the United States is vast and generates about $20 billion each year from over 100 million dieters. Commercial weight loss programs design customer-focused program policies to shape and optimize satisfaction and development.

Bortezomib reduces inflammation and promotes bone healing in arthritis models

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Safety rules lag in biotech industry

The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."

Read more Medical News

› Verified 6 days ago

• 1(current)
• 2